Tech Company Financing Transactions
NeuroVision Funding Round
On 5/3/2018, NeuroVision received $15 million in Series C investment from Wildcat Capital Management, Johnson & Johnson Development Corporation and Nikon-SBI Innovation Fund.
Transaction Overview
Company Name
Announced On
5/3/2018
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series C
Investors
Wildcat Capital Management (Lead Investor) (Leonard Potter)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1395 Garden Hwy. 250
Sacramento, CA 95833
USA
Sacramento, CA 95833
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer's Disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Verdooner
VP - Finance
Joanna Coleman
VP - Operations
Alan Czeszynski
VP - Regulatory Affairs
Pepe Davis
Browse more venture capital transactions:
Prev: 5/3/2018: Avedro venture capital transaction
Next: 5/3/2018: Rapid Micro Biosystems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs